c-Myc Inhibits Macrophage Antimycobacterial Response in Mycobacterium tuberculosis Infection
Sarti E, Dollé C, Wolfensberger R, Kusejko K, Russenberger D, Bredl S, Speck RF, Greter M, et al. (18 authors)
The Journal of infectious diseases · 2025-10
Abstract
Background Mycobacterium tuberculosis (MTB) remains a major cause of global mortality, yet natural immunity prevents disease in more than 90% of exposed individuals. Interferon gamma (IFN-γ) is a critical regulator of innate immunity and enhances macrophage antimicrobial responses. Methods Using in vitro systems approaches, we compared the effects of IFN-γ exposure before versus after infection. We manipulated c-Myc in primary macrophages with a tetracycline-inducible lentiviral system. c-Myc expression was also analyzed in tissues from murine tuberculosis models and human granulomas. Results Preinfection IFN-γ exposure primed macrophages for enhanced bacterial control, whereas postinfection exposure did not. We identified c-Myc signaling as a central determinant of macrophage antimycobacterial function. Inhibition of c-Myc via Omomyc enhanced bacterial control partly through mTORC1-dependent metabolic reprogramming and nitric oxide production. In vivo analyses, including murine models and human clinical histopathology, revealed strong associations between c-Myc expression, MTB persistence, and active tuberculosis. Conclusion c-Myc mediates immune privilege in MTB infection and represents a promising target for host-directed therapies to enhance macrophage function.
MeSH terms
- Macrophages
- Animals
- Mice, Inbred C57BL
- Humans
- Mice
- Mycobacterium tuberculosis
- Tuberculosis
- Granuloma
- Disease Models, Animal
- Nitric Oxide
- Proto-Oncogene Proteins c-myc
- Signal Transduction
- Female
- Immunity, Innate
- Interferon-gamma